Article citationsMore>>

Lu, M., Wang, X.C., Shen, L., Jia, J., Gong, J.F., Li, J., Li, J., Li, Y., Zhang, X.T., Lu, Z.H., Zhou, J. and Zhang, X.Z. (2016) Nimotuzumab Plus Paclitaxel and Cisplatin as the First Line Treatment for Advanced Esophageal Squamous Cell Cancer: A Single Centre Prospective Phase II Trial. Cancer Science, 170, 486-490.
https://doi.org/10.1111/cas.12894

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top